0001140361-16-054004.txt : 20160218
0001140361-16-054004.hdr.sgml : 20160218
20160218184415
ACCESSION NUMBER: 0001140361-16-054004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160216
FILED AS OF DATE: 20160218
DATE AS OF CHANGE: 20160218
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edge Therapeutics, Inc.
CENTRAL INDEX KEY: 0001472091
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264231384
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 CONNELL DRIVE
STREET 2: SUITE 1600
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
BUSINESS PHONE: 800-208-3343
MAIL ADDRESS:
STREET 1: 200 CONNELL DRIVE
STREET 2: SUITE 1600
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Einhorn Andrew J.
CENTRAL INDEX KEY: 0001560685
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37568
FILM NUMBER: 161439433
MAIL ADDRESS:
STREET 1: C/O MYOS CORPORATION
STREET 2: 45 HORSEHILL ROAD, SUITE 106
CITY: CEDAR KNOLLS
STATE: NJ
ZIP: 07927
4
1
doc1.xml
FORM 4
X0306
4
2016-02-16
0
0001472091
Edge Therapeutics, Inc.
EDGE
0001560685
Einhorn Andrew J.
200 CONNELL DRIVE
SUITE 1600
BERKELEY HEIGHTS
NJ
07922
0
1
0
0
Chief Financial Officer
Stock Option (Right to Purchase)
6.99
2016-02-16
4
A
0
50000
0
A
2026-02-16
Common Stock
50000
50000
D
This option, representing a right to purchase a total of 50,000 shares of Common Stock, will become exercisable on February 16, 2017, with 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.
/s/ Andrew J. Einhorn
2016-02-18